Graham Capital Management, L.P. Takeda Pharmaceutical CO LTD Transaction History
Graham Capital Management, L.P.
- $5.17 Billion
- Q2 2025
A detailed history of Graham Capital Management, L.P. transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Graham Capital Management, L.P. holds 49,286 shares of TAK stock, worth $662,403. This represents 0.01% of its overall portfolio holdings.
Number of Shares
49,286
Previous 158,760
68.96%
Holding current value
$662,403
Previous $2.36 Million
67.75%
% of portfolio
0.01%
Previous 0.05%
Shares
3 transactions
Others Institutions Holding TAK
# of Institutions
379Shares Held
73.2MCall Options Held
1.68MPut Options Held
157K-
Capital Research Global Investors Los Angeles, CA13.3MShares$179 Million0.04% of portfolio
-
Morgan Stanley New York, NY7.62MShares$102 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.5MShares$60.5 Million0.01% of portfolio
-
Ubs Group Ag4.02MShares$54.1 Million0.01% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA3.71MShares$49.9 Million0.54% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $41.8B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...